Abstract Purpose of Review To provide an updated summary and appraisal of work from
2019 to 2022 examining risks of selective serotonin reuptake inhibitor (SSRI) use in …

The developmental impact of selective serotonin reuptake inhibitor (SSRI) and other
antidepressant treatments during gestation and postpartum on anxiety and depression …

Importance Clinical decision-making on antidepressant treatment during pregnancy,
particularly selective serotonin reuptake inhibitors (SSRIs), is challenging, as both prenatal …

Background Women prescribed antidepressants face the dilemma of whether or not to
continue their treatment during pregnancy. Currently, limited evidence is available on the …

Many preclinical and clinical studies have examined the potential benefits of ginger extracts
for a range of medical disorders. Ginger has been found to reduce both pain and nausea …

Abstract Many (> 40%) women discontinue antidepressants during pregnancy because of
concerns about effects on the foetus, based on information from inadequately-controlled …

Importance Concerns exist about long-term neurodevelopmental consequences of prenatal
exposure to antidepressants. Objective To evaluate whether maternal prescription fill for …

Maternal depression in pregnancy is common, and selective serotonin reuptake inhibitors
(SSRIs) are the most frequently prescribed antidepressant medications used for its …

Background Selective serotonin reuptake inhibitors (SSRIs) are the most frequently
prescribed antidepressants in pregnancy. Animal and some clinical studies have suggested …

Despite growing concern about reproductive safety of psychotropic drugs, there is a paucity
of research assessing prenatal prescribing practices for bipolar disorder (BD). This …